openPR Logo
Press release

NGS Based RNA Sequencing Market Report Future Business Growth, Outlines Revenue - Illumina, Inc., Thermo Fischer Scientific Inc., Agilent Technologies, Inc.

10-10-2024 02:50 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

NGS Based RNA Sequencing Market || 2024-2031

NGS Based RNA Sequencing Market || 2024-2031

DataM Intelligence has released a new research report on the NGS Based RNA Sequencing market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

NGS based RNA Sequencing Market is predicted to reach at a CAGR of 19.7% during the forecast period (2024-2031).

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/ngs-based-rna-sequencing-market

NGS-based RNA sequencing, or Next-Generation Sequencing RNA Sequencing, is a high-throughput technique that allows for the comprehensive analysis of the transcriptome-the complete set of RNA transcripts produced by the genome under specific conditions. This method employs advanced sequencing technologies to rapidly and accurately determine the sequences of RNA molecules, providing insights into gene expression, alternative splicing, and post-transcriptional modifications. NGS-based RNA sequencing enables researchers to quantify RNA levels, identify novel transcripts, and study gene regulation on a large scale, facilitating advancements in areas such as personalized medicine, cancer research, and developmental biology.

List of the Key Players in the NGS Based RNA Sequencing Market:

Illumina, Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd, Hamilton Company, and Takara Bio Inc.

Key Developments:

NGS-based RNA sequencing presents numerous advantages over traditional transcriptome analysis methods, particularly due to its cost-effectiveness and efficiency. By enabling direct quantification and identification of transcripts, this approach has become the standard for investigating and optimizing mammalian cells. Unlike microarrays, NGS-based RNA sequencing eliminates issues related to non-ideal hybridization and cross-hybridization, resulting in higher specificity and more accurate data. It provides absolute values across a broad dynamic range of expression levels and is capable of detecting novel transcripts, making it a viable alternative to whole-genome transcriptome profiling. Collectively, these benefits are driving the growth of the NGS-based RNA sequencing market throughout the analysis period.

Research Process:

Both primary and secondary data sources have been used in the global NGS Based RNA Sequencing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the NGS Based RNA Sequencing Market:

By Product & Services: Sequencing Platform and Consumables, Sequencing Services

By Technology: Nanopore Sequencing, Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing

By Application: Drug Discovery, Diagnostics, Precision Medicine, Others

By End-user: Biotechnology and Pharmaceutical Companies, Research Centers, Academic and Government Institutes, Hospitals and Clinics, Others

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ngs-based-rna-sequencing-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, NGS Based RNA Sequencing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global NGS Based RNA Sequencing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global NGS Based RNA Sequencing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the NGS Based RNA Sequencing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/ngs-based-rna-sequencing-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the NGS Based RNA Sequencing market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the NGS Based RNA Sequencing market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the NGS Based RNA Sequencing market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release NGS Based RNA Sequencing Market Report Future Business Growth, Outlines Revenue - Illumina, Inc., Thermo Fischer Scientific Inc., Agilent Technologies, Inc. here

News-ID: 3687068 • Views:

More Releases from DataM Intelligence 4market Research LLP

DNA/RNA Extraction Kit Market to Continue Impressive Measured Growth through 2031 | Thermo Fisher Scientific Inc, Primerdesign, QIAGEN N.V.
DNA/RNA Extraction Kit Market to Continue Impressive Measured Growth through 203 …
DataM Intelligence has released a new research report on the DNA/RNA Extraction Kit market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like
Pulmonary Edema Therapeutics Market Latest Trends, Future Growth, Industry Analysis, Development, Opportunities, and Forecasts to 2031 | Pfizer Inc., sanofi-aventis U.S. LLC, Purdue Phanna L.P.
Pulmonary Edema Therapeutics Market Latest Trends, Future Growth, Industry Analy …
DataM Intelligence has released a new research report on the Pulmonary Edema Therapeutics market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like
Alternative Sweeteners Market Report Outlines Revenue Share, SWOT Analysis and Players - Hill Pharmaceutical Co. Ltd., Archer Daniels Midland Company, DuPont Nutrition & Health.
Alternative Sweeteners Market Report Outlines Revenue Share, SWOT Analysis and P …
DataM Intelligence has released a new research report on the Alternative Sweeteners market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits,
Natural Language Processing in Healthcare and Life Sciences Market With Included Analysis of New Trends, Updates, and Forecast to 2031 | Inovalon India Pvt Ltd, Amazon Web Services, Inc. and 3M.
Natural Language Processing in Healthcare and Life Sciences Market With Included …
DataM Intelligence has released a new research report on the Natural Language Processing in Healthcare and Life Sciences market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and